University of Colorado, Denver
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Colorado, Denver sits in the top decile of US sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count).
University of Colorado, Denver: 1,283 sponsored US clinical trials, 265 recruiting.
University of Colorado, Denver sponsors 1,283 registered US clinical trials on ClinicalTrials.gov, 265 of them currently recruiting, and 830 completed. 121 of these trials are in Phase 3-4 (later-stage) and 245 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 23 trials.
Top-decile sponsor footprint
University of Colorado, Denver ranks in the top decile of sponsors by registered trial count (#21 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
830 of 908 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,283 total, page 10 of 26
3D Printing for Pre-Surgical Planning
NCT05144620
Alcohol and Cannabis Concentrates Co-Administration
NCT05999344
Improving Communication and Healthcare Outcomes for Patients With Communication Disabilities
NCT04697212
Radiotherapy in Combination With Atezolizumab Prior to Surgical Resection for HPV Unrelated HNSCC
NCT05053737
Quantification of Cannabinoids and Comparison to Post-Surgical Pain Medication Requirements and Surgical Outcomes
NCT04988490
Remote Temperature Data for Early Detection of Febrile Neutropenia
NCT05180838
Tele-Ultrasound: VIrtual Hands-on Education for Novice Users
NCT05013476
68Ga-PSMA-11 PET in Patients With Prostate Cancer
NCT05197257
Interpersonal Psychotherapy in Adolescents With Polycystic Ovary Syndrome
NCT06056453
Desogestrel-containing COCP Pharmacokinetic Validation Study
NCT05002738
Blueberry Intake and Infant Gut Health
NCT05006989
CBD for the Treatment of Alcohol Use Disorder
NCT04873453
KPT-9274 in Patients With Relapsed and Refractory Acute Myeloid Leukemia
NCT04914845
Growing Up Formula Versus Nutritional Supplements: Effect on Catch up Growth, Micronutrient Status, and Solid Foods Intake in Toddlers With Mild or Moderate Malnutrition
NCT05088590
Decision Making for Urinary Diversion in Patients With Bladder Cancer
NCT05111639
Information Visualizations to Enhance HIV-related Communication
NCT04564209
Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors
NCT03752203
Preventing Alcohol Exposed Pregnancy Among Urban Native Young Women: Mobile CHOICES
NCT04376346
Feasibility and Impact of Yoga in Obesity
NCT05031221
Salmon Intake and Gut Health in Adults
NCT04792216
Oral Amoxicillin and Cephalexin PK/PD in Neonates
NCT04916951
Werewolf Flow 50 During ACL Reconstruction
NCT04998656
Sex Hormone and Vascular Function in Women With CKD
NCT05471518
Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases
NCT04973007
Acute Application of Antibiotic Powder in Open Fracture Wounds
NCT04872400
Should Graf IIc Hips be Treated for 12 Weeks
NCT03275805
Cardiac Output in Heart Failure Patients With Mechanical Pumps
NCT05195931
Virtually-integrated Co-management Between Complex Care and Community-based Primary Care Providers
NCT03530709
Discontinuation of Disease Modifying Therapies (DMTs) in Multiple Sclerosis (MS): Extension of the DISCOMS Study
NCT04754542
Second Opinions in Oncology
NCT05102500
Effects of Aromatherapy on Patient Satisfaction With Surgical Abortion at Less Than 10 Weeks Gestation
NCT04969900
Myocardial Injury and Dysfunction Associated With COVID-19 Vaccination
NCT05359250
Opioid Modulation and Neural Reward Activation in Healthy Adults
NCT04854551
NanoSilk Cosmo: Evaluation of a Novel Silk Complex on Biophysical Parameters Related to Skin Aging
NCT04630418
Alzheimer's Disease and Precision Medicine Research Among Native People
NCT03448601
Substance Use Disorder (SUD)-Associated Infections' Treatment With Dalbavancin ENabling OUtpatient Transition
NCT04847921
Youth PHP Pilot Transdiagnostic Treatment Implementation and Effectiveness Study
NCT04792151
Effect of Hormone Therapy on Renal Function
NCT04482920
Blood Transfusion Reduction - QI Project
NCT04823273
Social Convoy Palliative Care (Convoy-Pal) Mobile Health for Older Adults
NCT04779931
Swelling Management After Total Knee Arthroplasty
NCT04841356
The Effects of Orchiectomy and Age on Vascular and Metabolic Health in Older Versus Younger Transgender Women
NCT05195164
School-Based Treatment for Early Childhood Anxiety
NCT04811482
A Mobile Intervention Merging Yoga and Self-Management Skills
NCT04758312
Low Load Resistance Training Using Blood Flow Restriction for People With Multiple Sclerosis
NCT04633759
Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine
NCT04522674
A Health System Wide Evaluation of Clinical Decision Support Tools to Improve PDMP Utilization and Patient Outcomes
NCT04918355
Observational Study of Actigraphy in Pediatric Pulmonary Arterial Hypertension
NCT04745000
Discharge in the AM
NCT05370638
Time Restricted Feeding in Autosomal Dominant Polycystic Kidney Disease
NCT04534985
What is open in the University of Colorado, Denver pipeline
265 recruiting of 1,283 indexed (21% open); 830 completed (65%).
Phase mix: 121 late (III/IV) vs 245 early (I/II) (early-phase heavy).
Top condition: Obesity (23 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Colorado, Denver: open-pipeline peers nationwide
Peers matched on 1,283 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
University of Colorado, Denver sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,283 trials (± recruiting share)
- AstraZeneca · 1,285 trials · 12% recruiting
- University of Michigan · 1,327 trials · 13% recruiting
- University of Pittsburgh · 1,238 trials · 13% recruiting
- Eli Lilly and Company · 1,341 trials · 9% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Cedars-Sinai Medical Center · 21% recruiting · 339 trials
- Craig Hospital · 21% recruiting · 29 trials
- W.L.Gore & Associates · 21% recruiting · 53 trials
- Georgia Institute of Technology · 21% recruiting · 24 trials
Related
What to do with this University of Colorado, Denver page
1,283 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Denver or any single study.
- 265 of University of Colorado, Denver's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Colorado, Denver studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Colorado, Denver pipeline card: 1,283 registered trials from official public datasets.Report a data error.